Wall Street slipped on Thursday as disappointing results from Meta and cautious tones from the Fed weighed on sentiment. But after the closing bell, Apple’s record-breaking numbers helped restore a bit of optimism.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently -
over the past six months, the collective 9.8% gain for healthcare stocks has fallen short of the S&P 500’s 22.6% rise.
The U.S. stock market opened with a palpable sense of divergence on October 30, 2025, as investors grappled with a mixed bag of quarterly earnings and forward-looking statements from the nation's technology giants. While the venerable Dow Jones Industrial Average (DJIA) managed a modest ascent, both the broader S&
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell th
Nvidia's $5 trillion valuation record is igniting momentum across semiconductor and AI-themed ETFs as investors chase the next leg of the chip supercycle.
The Dow Jones Industrial Average (DJIA) finds itself navigating a complex economic landscape as of October 30, 2025, exhibiting resilience despite a barrage of mixed signals from central bank policies, crucial economic data delays, and evolving geopolitical dynamics. Investopedia's analysis points to a market grappling with the Federal Reserve's delicate
Eli Lilly's Q3 2025 results crushed estimates, driven by high demand for Mounjaro and Zepbound. The company raised its full-year outlook, sparking a stock rally.
Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 53.9% year on year to $17.6 billion. The company’s full-year revenue guidance of $63.25 billion at the midpoint came in 2.6% above analysts’ estimates. Its non-GAAP profit of $7.02 per share was 18.6% above analysts’ consensus estimates.
The global stock market is currently navigating an unprecedented era of record-breaking growth in late October 2025, a phenomenon largely orchestrated by the remarkable performance and pervasive influence of the technology sector, with Artificial Intelligence (AI) at its core. Major U.S. indices, including the S&P 500, Dow Jones Industrial Average, and Nasdaq Composite, have consistently [...]
